B M McGuire
Affiliation: University of Alabama at Birmingham
- Safety of endoscopy in patients with end-stage liver diseaseB M McGuire
University of Alabama at Birmingham Liver Center, Birmingham, Alabama 35294 0007, USA
Gastrointest Endosc Clin N Am 11:111-30. 2001....
- Current trends in the treatment of hepatic encephalopathyMohamad Rasm Al Sibae
Department of Medicine, Division of Gastroenterology and Hepatology, University of Alabama at Birmingham, Birmingham, AL, USA
Ther Clin Risk Manag 5:617-26. 2009....
- Hepatic encephalopathy: a review of its pathophysiology and treatmentNader Dbouk
University of Alabama at Birmingham, Department of Medicine, 1530 Third Avenue South, MCLM 262A, Birmingham, AL 35294 0005, USA
Curr Treat Options Gastroenterol 9:464-74. 2006..These include manganese chelators, L-carnitine, N-methyl-d-aspartate receptor antagonists, blood purification dialysis system, and an intravenous combination of sodium benzoate and phenylacetate...
- Long-term management of the liver transplant patient: recommendations for the primary care doctorB M McGuire
University of Alabama at Birmingham, Birmingham, AL, USA
Am J Transplant 9:1988-2003. 2009..These guidelines are intended to provide a bridge between transplant centers and primary care physicians in the long-term management of the liver transplant patient...
- Brief communication: Glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantationBrendan M McGuire
University of Alabama at Birmingham, Birmingham, Alabama 35294 0005, USA
Ann Intern Med 144:735-41. 2006..Patients infected with hepatitis C virus (HCV) frequently develop renal failure after liver transplantation...
- Liver transplantation for erythropoietic protoporphyria liver diseaseBrendan M McGuire
Department of Medicine, University of Alabama at Birmingham, 1530 Third Avenue South, Birmingham, AL 35294 0005, USA
Liver Transpl 11:1590-6. 2005..In conclusion, the 5-year patient survival rate in patients transplanted for EPP liver disease is good, but the recurrence of EPP liver disease appears to diminish long term graft and patient survival...
- The critically ill liver patient: fulminant hepatic failureBrendan M McGuire
Division of Gastroenterology and Hepatology, UAB Liver Center, University of Alabama at Birmingham, UAB Liver Center, 1918 University Blvd, Birmingham, AL 35294 0005, USA
Semin Gastrointest Dis 14:39-42. 2003..This case illustrates many of the problems that are encountered during medical management of fulminant hepatic failure...
- Combined cardiac surgery and liver transplantationD E Eckhoff
Department of Surgery, Division of Transplant Immunobiology and Transplant Center, University of Alabama, Birmingham, USA
Liver Transpl 7:60-1. 2001..Convalescence was uneventful, and at 2 years after the procedure, the patient has normal cardiac function, good prosthetic valve function, and biochemically normal liver function...
- Complications of cirrhosis. Why they occur and what to do about themB M McGuire
Liver Center, University of Alabama at Birmingham 35294 0005, USA
Postgrad Med 103:209-12, 217-8, 223-4. 1998..Patient management should consist of appropriate prophylaxis for the life-threatening complications of variceal bleeding and spontaneous bacterial peritonitis and treatment of other complications as signs and symptoms develop...
- Intermittent unexplained abdominal pain: is it porphyria?Joseph R Bloomer
Liver Center and Division of Gastroenterology Hepatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama 35294 0005, USA
Clin Gastroenterol Hepatol 5:1255-8; quiz 1244. 2007
- Electrophoretic methods for analysis of urinary polypeptides in IgA-associated renal diseasesBruce A Julian
Division of Nephrology, University of Alabama at Birmingham, Birmingham, AL 35294, USA
Electrophoresis 28:4469-83. 2007....
- Use of preserved vascular homografts in liver transplantation: hepatic artery aneurysms and other complicationsMarty T Sellers
Department of Surgery, University of Alabama at Birmingham, Birmingham, AL 35294, USA
Am J Transplant 2:471-5. 2002..In conclusion, properly preserved vascular homografts are useful in LT for purposes other than initial vascular reconstruction. They also provide an excellent vascular conduit in recipients of livers from other (possibly living) donors...
- Urinary biomarkers of IgA nephropathy and other IgA-associated renal diseasesBruce A Julian
Department of Medicine, University of Alabama at Birmingham, 1530 Third Avenue South, Birmingham, AL 35294, USA
World J Urol 25:467-76. 2007....
- The use of screening and preventive therapies for gastroesophageal varices in patients referred for evaluation of orthotopic liver transplantationM R Arguedas
Department of Medicine, UAB Liver Center, University of Alabama at Birmingham, 35294-0007, USA
Am J Gastroenterol 96:833-7. 2001..Therefore, the adherence to currently available practice guidelines and the education of physicians to implement screening in this patient population is an important goal...
- Outpatient management of cirrhosis: a narrative reviewRonnie E Mathews
Division of General Internal Medicine, Department of Medicine, University of Alabama at Birmingham, USA
South Med J 99:600-6. 2006..The outpatient management of these complications will be discussed in this paper, along with the use of vaccinations, educating patients about the avoidance of hepatotoxic drugs, and when to refer a patient for liver transplant...
- Impact of noncompliance and donor/recipient race matching on chronic liver rejectionS V Haustein
Department of Surgery, Division of Transplantation, University of Alabama at Birmingham, Birmingham, AL 35223, USA
Transplant Proc 34:1497-8. 2002
- HFE hemochromatosis and hepatic sarcoidJames C Barton
Southern Iron Disorders Center, Birmingham, Alabama, USA
Am J Med Sci 337:386-90. 2009..We reviewed previous reports of 4 patients with hemochromatosis and sarcoid. We conclude that a combination of sarcoid, steatosis, and excessive hepatocyte iron caused cirrhosis or hepatic fibrosis in the proband and her son...
- Implementation of vaccination in patients with cirrhosisMiguel R Arguedas
Department of Medicine, University of Alabama at Birmingham, 35294 0007, USA
Dig Dis Sci 47:384-7. 2002..In conclusion, vaccination for viral hepatitis, pneumococcus, and influenza not being consistently performed. Public health efforts aimed at raising awareness about implementing vaccination in these patients are strongly encouraged...
- Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosisMiguel R Arguedas
Department of Medicine, Division of Gastroenterology and Hepatology, University of Alabama at Birmingham, Birmingham, Alabama, USA
Dig Dis Sci 48:1622-6. 2003..Overt hepatic encephalopathy negatively affects both physical and mental aspects of quality of life, whereas subclinical encephalopathy affects mainly the mental aspects, independently of liver disease severity...
- Pharmacology and safety of glycerol phenylbutyrate in healthy adults and adults with cirrhosisBrendan M McGuire
University of Alabama, Birmingham, AL, USA
Hepatology 51:2077-85. 2010..Cirrhotic subjects converted GPB to PAGN similarly to healthy adults. Simulations suggest that GPB can be administered safely to cirrhotic subjects at levels equivalent to the highest approved NaPBA dose for UCDs...
- Two-dose daclizumab induction therapy in 209 liver transplants: a single-center analysisMarty T Sellers
Department of Surgery, University of Pennsylvania, 3400 Spruce Street, 4 Silverstein, Philadelphia, PA 19104, USA
Transplantation 78:1212-7. 2004..Therefore, our immunosuppressive strategies should be as "renal sparing" as possible. This is the largest published series to date using daclizumab induction therapy in a renal-sparing regimen...
- Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study GroupR Todd Stravitz
Section of Hepatology, Virginia Commonwealth University, Richmond, USA
Crit Care Med 35:2498-508. 2007..To provide a uniform platform from which to study acute liver failure, the U.S. Acute Liver Failure Study Group has sought to standardize the management of patients with acute liver failure within participating centers...
- Retransplantation for hepatitis C: results of a U.S. multicenter retransplant studyTimothy McCashland
Department of Hepatology, University of Nebraska Medical Center, Omaha, NE 68198 3285, USA
Liver Transpl 13:1246-53. 2007..MELD scores were not predictive of post-reTX survival. Survival was <50% in the non-HCV reTx group with MELD score of >30. Many patients with recurrent HCV are not considered for reTX and die from recurrent disease...
- Use of extracorporeal albumin dialysis for erythropoietic protoporphyriaBrendan M McGuire
Liver Transpl 13:639-40. 2007
- Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study groupRobert H Squires
University of Pittsburgh, Children s Hospital of Pittsburgh, PA 15213, USA
J Pediatr 148:652-658. 2006..To determine short-term outcome for children with acute liver failure (ALF) as it relates to cause, clinical status, and patient demographics and to determine prognostic factors...